Edwards Lifesciences SG&A Expenses 2010-2024 | EW

Edwards Lifesciences annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Edwards Lifesciences sg&a expenses for the quarter ending September 30, 2024 were $0.421B, a 10.34% increase year-over-year.
  • Edwards Lifesciences sg&a expenses for the twelve months ending September 30, 2024 were $1.958B, a 19.41% increase year-over-year.
  • Edwards Lifesciences annual sg&a expenses for 2023 were $1.825B, a 16.39% increase from 2022.
  • Edwards Lifesciences annual sg&a expenses for 2022 were $1.568B, a 4.95% increase from 2021.
  • Edwards Lifesciences annual sg&a expenses for 2021 were $1.494B, a 21.6% increase from 2020.
Edwards Lifesciences Annual SG&A Expenses
(Millions of US $)
2023 $1,825
2022 $1,568
2021 $1,494
2020 $1,228
2019 $1,242
2018 $1,089
2017 $991
2016 $905
2015 $851
2014 $858
2013 $733
2012 $697
2011 $642
2010 $550
2009 $509
Edwards Lifesciences Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $421
2024-06-30 $451
2024-03-31 $490
2023-12-31 $596
2023-09-30 $382
2023-06-30 $410
2023-03-31 $436
2022-12-31 $411
2022-09-30 $377
2022-06-30 $409
2022-03-31 $370
2021-12-31 $424
2021-09-30 $364
2021-06-30 $375
2021-03-31 $331
2020-12-31 $339
2020-09-30 $307
2020-06-30 $275
2020-03-31 $308
2019-12-31 $347
2019-09-30 $306
2019-06-30 $309
2019-03-31 $280
2018-12-31 $288
2018-09-30 $270
2018-06-30 $275
2018-03-31 $256
2017-12-31 $273
2017-09-30 $245
2017-06-30 $244
2017-03-31 $230
2016-12-31 $234
2016-09-30 $230
2016-06-30 $229
2016-03-31 $213
2015-12-31 $222
2015-09-30 $212
2015-06-30 $214
2015-03-31 $203
2014-12-31 $223
2014-09-30 $222
2014-06-30 $216
2014-03-31 $197
2013-12-31 $187
2013-09-30 $178
2013-06-30 $187
2013-03-31 $182
2012-12-31 $170
2012-09-30 $168
2012-06-30 $182
2012-03-31 $177
2011-12-31 $163
2011-09-30 $166
2011-06-30 $163
2011-03-31 $150
2010-12-31 $142
2010-09-30 $133
2010-06-30 $141
2010-03-31 $134
2009-12-31 $132
2009-09-30 $126
2009-06-30 $129
2009-03-31 $122
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.062B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $211.041B 25.75
Intuitive Surgical (ISRG) United States $191.072B 99.90
Alcon (ALC) Switzerland $45.679B 32.16
IQVIA Holdings (IQV) United States $39.790B 21.92
IDEXX Laboratories (IDXX) United States $35.479B 41.78
DexCom (DXCM) United States $27.326B 41.15
Waters (WAT) United States $22.831B 33.76
SONOVA HOLDING (SONVY) Switzerland $22.110B 0.00
STERIS (STE) Ireland $21.616B 24.91
Hologic (HOLX) United States $18.294B 19.30
Sysmex ADR (SSMXY) Japan $12.864B 40.34
Fresenius Medical Care AG KGaA (FMS) Germany $12.499B 12.83
Globus Medical (GMED) United States $10.952B 27.89
Teleflex (TFX) United States $9.082B 14.49
Penumbra (PEN) United States $9.075B 88.89
Masimo (MASI) United States $8.696B 42.08
Glaukos (GKOS) United States $7.816B 0.00
PROCEPT BioRobotics (PRCT) United States $5.170B 0.00
Integer Holdings (ITGR) United States $4.587B 26.00
Inari Medical (NARI) United States $3.009B 0.00
TransMedics (TMDX) United States $2.886B 91.47
LivaNova (LIVN) United Kingdom $2.804B 16.18
Veracyte (VCYT) United States $2.802B 84.84
Nihon Kohden (NHNKY) Japan $2.648B 20.12
Elekta AB (EKTAY) Sweden $2.286B 18.62
Tandem Diabetes Care (TNDM) United States $2.010B 0.00
Integra LifeSciences Holdings (IART) United States $1.912B 9.99
RxSight (RXST) United States $1.776B 0.00
Alphatec Holdings (ATEC) United States $1.333B 0.00
Pulse Biosciences (PLSE) United States $1.222B 0.00
Artivion (AORT) United States $1.203B 79.75
OPKO Health (OPK) United States $1.060B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.938B 15.95
ORTHOFIX MEDICAL INC (OFIX) United States $0.741B 0.00
IRadimed (IRMD) United States $0.716B 38.68
Mesa Laboratories (MLAB) United States $0.643B 15.22
SiBone (SIBN) United States $0.639B 0.00
Pacific Biosciences Of California (PACB) United States $0.627B 0.00
OrthoPediatrics (KIDS) United States $0.623B 0.00
Paragon 28 (FNA) United States $0.597B 0.00
AxoGen (AXGN) United States $0.555B 0.00
Treace Medical Concepts (TMCI) United States $0.501B 0.00
CVRx (CVRX) United States $0.377B 0.00
Tactile Systems Technology (TCMD) United States $0.360B 19.51
ClearPoint Neuro (CLPT) United States $0.321B 0.00
Delcath Systems (DCTH) United States $0.307B 0.00
AngioDynamics (ANGO) United States $0.293B 0.00
Semler Scientific (SMLR) United States $0.289B 19.43
Inogen (INGN) United States $0.263B 0.00
NeuroPace (NPCE) United States $0.219B 0.00
Accuray (ARAY) United States $0.216B 0.00
Sight Sciences (SGHT) United States $0.213B 0.00
Nevro (NVRO) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
Alpha Tau Medical (DRTS) Israel $0.158B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.124B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.111B 16.51
EDAP TMS S.A (EDAP) France $0.095B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
Hyperfine (HYPR) United States $0.069B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.056B 0.00
Rapid Micro Biosystems (RPID) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.050B 0.00
Accelerate Diagnostics (AXDX) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.041B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
NexGel (NXGL) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00